NCT03575819 2024-02-01A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Fortis Therapeutics, Inc.Phase 1 Completed56 enrolled
NCT03024216 2021-05-26Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate CancerUniversity of HawaiiPhase 1 Completed37 enrolled